Vir Biotechnology Inc (VIR)
6.965
+0.22
(+3.34%)
USD |
NASDAQ |
Nov 21, 16:00
6.965
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Market Cap: 959.22M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 928.23M |
| November 19, 2024 | 954.40M |
| November 18, 2024 | 968.17M |
| November 15, 2024 | 1.103B |
| November 14, 2024 | 1.190B |
| November 13, 2024 | 1.237B |
| November 12, 2024 | 1.274B |
| November 11, 2024 | 1.359B |
| November 08, 2024 | 1.322B |
| November 07, 2024 | 1.346B |
| November 06, 2024 | 1.401B |
| November 05, 2024 | 1.328B |
| November 04, 2024 | 1.290B |
| November 01, 2024 | 1.275B |
| October 31, 2024 | 1.032B |
| October 30, 2024 | 1.047B |
| October 29, 2024 | 1.048B |
| October 28, 2024 | 1.067B |
| October 25, 2024 | 1.030B |
| October 24, 2024 | 1.005B |
| October 23, 2024 | 1.028B |
| October 22, 2024 | 1.040B |
| October 21, 2024 | 1.046B |
| October 18, 2024 | 1.043B |
| October 17, 2024 | 1.055B |
| Date | Value |
|---|---|
| October 16, 2024 | 1.076B |
| October 15, 2024 | 1.059B |
| October 14, 2024 | 1.049B |
| October 11, 2024 | 1.038B |
| October 10, 2024 | 1.003B |
| October 09, 2024 | 1.002B |
| October 08, 2024 | 1.001B |
| October 07, 2024 | 1.012B |
| October 04, 2024 | 1.058B |
| October 03, 2024 | 1.002B |
| October 02, 2024 | 1.050B |
| October 01, 2024 | 1.034B |
| September 30, 2024 | 1.024B |
| September 27, 2024 | 1.029B |
| September 26, 2024 | 997.47M |
| September 25, 2024 | 992.00M |
| September 24, 2024 | 1.030B |
| September 23, 2024 | 1.038B |
| September 20, 2024 | 1.060B |
| September 19, 2024 | 1.085B |
| September 18, 2024 | 1.066B |
| September 17, 2024 | 1.084B |
| September 16, 2024 | 1.075B |
| September 13, 2024 | 1.108B |
| September 12, 2024 | 1.074B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
928.23M
Minimum
Nov 20 2024
10.58B
Maximum
Jan 27 2021
3.425B
Average
3.365B
Median
Market Cap Benchmarks
| Pfizer Inc | 142.44B |
| Biomarin Pharmaceutical Inc | 12.09B |
| Arbutus Biopharma Corp | 655.64M |
| GlycoMimetics Inc | 20.71M |
| FibroGen Inc | 38.92M |
Market Cap Related Metrics
| PS Ratio | 15.24 |
| Price to Book Value | 0.7731 |
| Price | 6.965 |
| Earnings Yield | -56.28% |